Datapulse Tech BKW

SGD 0.15 +0.00% +0.00 Updated 23 Oct 2026, 17:16 SGT
+ Add holding ☆ Watchlist Email updates Compare
More
My transactions Market links SGXGoogleYahooTradingView

Financials

Annual Report 2025

Open annual report

Auditor’s opinion: a true and fair view. Read auditor’s report (PDF p. 61)

Explore the statements

34 tables

Group statement of financial position

26 metrics

Units appear below each metric. Scroll to compare years

Group statement of financial position from Annual Report 2025
Metric / unit 2025Group / as at 31 July 20252024Group / as at 31 July 2024 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 35,88938,100 PDF p. 69
Right-of-use assetsSingapore dollars thousands 4298 PDF p. 69
Investment securitiesSingapore dollars thousands 5,3824,282 PDF p. 69
Long-term receivablesSingapore dollars thousands 6,3056,305 PDF p. 69
SubsidiariesSingapore dollars thousands -- PDF p. 69
Deferred tax assetsSingapore dollars thousands 526509 PDF p. 69
Total non-current assetsSingapore dollars thousands 48,14449,294 PDF p. 69
Current assets
Trade and other receivablesSingapore dollars thousands 306218 PDF p. 69
PrepaymentSingapore dollars thousands 7660 PDF p. 69
Investment securitiesSingapore dollars thousands 3,880- PDF p. 69
Cash and bank balancesSingapore dollars thousands 10,63414,194 PDF p. 69
Total current assetsSingapore dollars thousands 14,89614,472 PDF p. 69
TOTAL ASSETSSingapore dollars thousands 63,04063,766 PDF p. 69
Equity attributable to owners of the Company
Share capitalSingapore dollars thousands 34,73634,736 PDF p. 69
ReservesSingapore dollars thousands 27,52227,117 PDF p. 69
Total equitySingapore dollars thousands 62,25861,853 PDF p. 69
Non-current liabilities
Loans and borrowingsSingapore dollars thousands -528 PDF p. 69
Lease liabilitiesSingapore dollars thousands -44 PDF p. 69
Total non-current liabilitiesSingapore dollars thousands -572 PDF p. 69
Current liabilities
Trade and other payablesSingapore dollars thousands 721750 PDF p. 69
Current tax payableSingapore dollars thousands 1632 PDF p. 69
Loans and borrowingsSingapore dollars thousands -500 PDF p. 69
Lease liabilitiesSingapore dollars thousands 4559 PDF p. 69
Total current liabilitiesSingapore dollars thousands 7821,341 PDF p. 69
Total liabilitiesSingapore dollars thousands 7821,913 PDF p. 69
TOTAL EQUITY AND LIABILITIESSingapore dollars thousands 63,04063,766 PDF p. 69
Definitions & sources

Original report: PDF p. 69 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Company statement of financial position

26 metrics

Units appear below each metric. Scroll to compare years

Company statement of financial position from Annual Report 2025
Metric / unit 2025Company / as at 31 July 20252024Company / as at 31 July 2024 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 1413 PDF p. 69
Right-of-use assetsSingapore dollars thousands 4298 PDF p. 69
Investment securitiesSingapore dollars thousands -- PDF p. 69
Long-term receivablesSingapore dollars thousands -- PDF p. 69
SubsidiariesSingapore dollars thousands 52,65351,368 PDF p. 69
Deferred tax assetsSingapore dollars thousands -- PDF p. 69
Total non-current assetsSingapore dollars thousands 52,70951,479 PDF p. 69
Current assets
Trade and other receivablesSingapore dollars thousands 9053 PDF p. 69
PrepaymentSingapore dollars thousands 4151 PDF p. 69
Investment securitiesSingapore dollars thousands 3,880- PDF p. 69
Cash and bank balancesSingapore dollars thousands 7,93511,329 PDF p. 69
Total current assetsSingapore dollars thousands 11,94611,433 PDF p. 69
TOTAL ASSETSSingapore dollars thousands 64,65562,912 PDF p. 69
Equity attributable to owners of the Company
Share capitalSingapore dollars thousands 34,73634,736 PDF p. 69
ReservesSingapore dollars thousands 29,70126,819 PDF p. 69
Total equitySingapore dollars thousands 64,43761,555 PDF p. 69
Non-current liabilities
Loans and borrowingsSingapore dollars thousands -528 PDF p. 69
Lease liabilitiesSingapore dollars thousands -44 PDF p. 69
Total non-current liabilitiesSingapore dollars thousands -572 PDF p. 69
Current liabilities
Trade and other payablesSingapore dollars thousands 173226 PDF p. 69
Current tax payableSingapore dollars thousands -- PDF p. 69
Loans and borrowingsSingapore dollars thousands -500 PDF p. 69
Lease liabilitiesSingapore dollars thousands 4559 PDF p. 69
Total current liabilitiesSingapore dollars thousands 218785 PDF p. 69
Total liabilitiesSingapore dollars thousands 2181,357 PDF p. 69
TOTAL EQUITY AND LIABILITIESSingapore dollars thousands 64,65562,912 PDF p. 69
Definitions & sources

Original report: PDF p. 69 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group consolidated profit or loss and comprehensive income

22 metrics

Units appear below each metric. Scroll to compare years

Group consolidated profit or loss and comprehensive income from Annual Report 2025
Metric / unit 2025Group / year ended 31 July 20252024Group / year ended 31 July 2024 Source
income
RevenueSingapore dollars thousands 6,0556,186 PDF p. 68
Other incomeSingapore dollars thousands 281421 PDF p. 68
Revenue and other income subtotal (unlabelled in source)Singapore dollars thousands 6,3366,607 PDF p. 68
Gain on fair value of investmentsSingapore dollars thousands 61- PDF p. 68
Staff costsSingapore dollars thousands (1,322)(1,506) PDF p. 68
Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands (569)(611) PDF p. 68
Finance costsSingapore dollars thousands (15)(38) PDF p. 68
Hotel operating expensesSingapore dollars thousands (2,406)(2,528) PDF p. 68
Reversal of impairment of freehold buildingSingapore dollars thousands -2,910 PDF p. 68
Other operating expensesSingapore dollars thousands (1,288)(1,209) PDF p. 68
Profit before taxationSingapore dollars thousands 7973,625 PDF p. 68
TaxationSingapore dollars thousands 25892 PDF p. 68
Profit for the yearSingapore dollars thousands 8224,517 PDF p. 68
Components of other comprehensive (loss)/income that will not be
Remeasurement of defined benefit obligationSingapore dollars thousands (8)(22) PDF p. 68
Net gain/(loss) on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands 1,100(20) PDF p. 68
Components of other comprehensive loss that will be reclassified to profit
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands (1,509)(2,280) PDF p. 68
Total other comprehensive loss, net of taxationSingapore dollars thousands (417)(2,322) PDF p. 68
TOTAL COMPREHENSIVE INCOME FOR THE YEARSingapore dollars thousands 4052,195 PDF p. 68
Profit attributable to:
Owners of the CompanySingapore dollars thousands 8224,517 PDF p. 68
Total comprehensive income attributable to:
Owners of the CompanySingapore dollars thousands 4052,195 PDF p. 68
Profit per share attributable to owners of the Company
Basic profit per share (cents)Singapore cents per share 0.351.89 PDF p. 68
Diluted profit per share (cents)Singapore cents per share 0.251.38 PDF p. 68
Definitions & sources

Original report: PDF p. 68 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group changes in equity / 2025

8 metrics

Units appear below each metric. Scroll to compare years

Group changes in equity / 2025 from Annual Report 2025
Metric / unit 2025Group / Share capital2025Group / Treasury shares2025Group / Fair value adjustment reserve2025Group / Foreign currency translation reserve2025Group / Warrant reserve2025Group / Retained earnings2025Group / Total equity Source
equity
Balance at 1 August 2024Singapore dollars thousands 34,736(187)(1,067)(8,192)75235,81161,853 PDF p. 70
Profit for the yearSingapore dollars thousands -----822822 PDF p. 70
Remeasurement of defined benefit obligationSingapore dollars thousands -----(8)(8) PDF p. 70
Net income on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands --1,100---1,100 PDF p. 70
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands ---(1,509)--(1,509) PDF p. 70
Total other comprehensive income/ (loss)Singapore dollars thousands --1,100(1,509)-(8)(417) PDF p. 70
Total comprehensive income/(loss) for the financial yearSingapore dollars thousands --1,100(1,509)-814405 PDF p. 70
Balance at 31 July 2025Singapore dollars thousands 34,736(187)33(9,701)75236,62562,258 PDF p. 70
Definitions & sources

Original report: PDF p. 70 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group changes in equity / 2024

10 metrics

Units appear below each metric. Scroll to compare years

Group changes in equity / 2024 from Annual Report 2025
Metric / unit 2024Group / Share capital2024Group / Treasury shares2024Group / Fair value adjustment reserve2024Group / Foreign currency translation reserve2024Group / Warrant reserve2024Group / Retained earnings2024Group / Total equity Source
equity
Balance at 1 August 2023Singapore dollars thousands 35,016(187)(1,047)(5,912)75231,31659,938 PDF p. 71
Profit for the yearSingapore dollars thousands -----4,5174,517 PDF p. 71
Remeasurement of defined benefit obligationSingapore dollars thousands -----(22)(22) PDF p. 71
Net loss on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands --(20)---(20) PDF p. 71
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands ---(2,280)--(2,280) PDF p. 71
Total other comprehensive lossSingapore dollars thousands --(20)(2,280)-(22)(2,322) PDF p. 71
Total comprehensive (loss)/income for the financial yearSingapore dollars thousands --(20)(2,280)-4,4952,195 PDF p. 71
Transactions with owners,
Purchase and cancellation of ordinary shares (Note 15)Singapore dollars thousands (280)-----(280) PDF p. 71
Transactions with owners subtotal (unlabelled in source)Singapore dollars thousands (280)-----(280) PDF p. 71
Balance at 31 July 2024Singapore dollars thousands 34,736(187)(1,067)(8,192)75235,81161,853 PDF p. 71
Definitions & sources

Original report: PDF p. 71 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group consolidated cash flows

31 metrics

Units appear below each metric. Scroll to compare years

Group consolidated cash flows from Annual Report 2025
Metric / unit 2025Group / year ended 31 July 20252024Group / year ended 31 July 2024 Source
Operating activities
Profit before taxationSingapore dollars thousands 7973,625 PDF p. 72
Adjustments for:
- Defined benefit costsSingapore dollars thousands 7617 PDF p. 72
- Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands 569610 PDF p. 72
- Finance costsSingapore dollars thousands 1538 PDF p. 72
- Reversal of impairment of freehold buildingSingapore dollars thousands -(2,910) PDF p. 72
- Gain on short-term investment securitiesSingapore dollars thousands (61)- PDF p. 72
- Foreign exchange loss (realised)Singapore dollars thousands 325- PDF p. 72
- Interest incomeSingapore dollars thousands (273)(421) PDF p. 72
Operating cash flows before movements in working capitalSingapore dollars thousands 1,448959 PDF p. 72
Changes in working capital:
- Trade and other receivablesSingapore dollars thousands (103)47 PDF p. 72
- PrepaymentSingapore dollars thousands (13)2 PDF p. 72
- Short-term investment securitiesSingapore dollars thousands (3,819)498 PDF p. 72
- Trade and other payablesSingapore dollars thousands (66)(40) PDF p. 72
- Contribution or benefits paid to retirement benefitsSingapore dollars thousands (65)(65) PDF p. 72
Cash (used in)/generated from operationsSingapore dollars thousands (2,618)1,401 PDF p. 72
Tax paidSingapore dollars thousands (31)(8) PDF p. 72
Net cash flows (used in)/generated from operating activitiesSingapore dollars thousands (2,649)1,393 PDF p. 72
Investing activities
Interest receivedSingapore dollars thousands 283479 PDF p. 72
Investment securitiesSingapore dollars thousands -(94) PDF p. 72
Purchase of property, plant and equipmentSingapore dollars thousands (16)(15) PDF p. 72
Net cash flows generated from investing activitiesSingapore dollars thousands 267370 PDF p. 72
Financing activities
Interest paidSingapore dollars thousands (13)(36) PDF p. 72
Purchase and cancellation of ordinary sharesSingapore dollars thousands -(280) PDF p. 72
Repayment of borrowingsSingapore dollars thousands (1,026)(492) PDF p. 72
Repayment of lease liabilitiesSingapore dollars thousands (60)(64) PDF p. 72
Movement in pledged depositSingapore dollars thousands 638(23) PDF p. 72
Net cash flow used in financing activitiesSingapore dollars thousands (461)(895) PDF p. 72
Net increase in cash and cash equivalentsSingapore dollars thousands (2,843)868 PDF p. 72
Cash and cash equivalents at beginning of financial yearSingapore dollars thousands 13,55612,782 PDF p. 72
Effect of exchange rate changes on balances held in foreign currencySingapore dollars thousands (79)(94) PDF p. 72
Cash and cash equivalents at end of financial yearSingapore dollars thousands 10,63413,556 PDF p. 72
Definitions & sources

Original report: PDF p. 72 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group financing reconciliation / 2025

3 metrics

Units appear below each metric. Scroll to compare years

Group financing reconciliation / 2025 from Annual Report 2025
Metric / unit 2025Group / At 1 August2025Group / Financing cash flows2025Group / Additions2025Group / Interest expenses2025Group / At 31 July Source
Liabilities
Bank borrowingsSingapore dollars thousands 1,028(1,041)-13- PDF p. 73
Lease liabilitiesSingapore dollars thousands 103(60)-245 PDF p. 73
Asset
Pledged depositSingapore dollars thousands (638)638--- PDF p. 73
Definitions & sources

Original report: PDF p. 73 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group financing reconciliation / 2024

3 metrics

Units appear below each metric. Scroll to compare years

Group financing reconciliation / 2024 from Annual Report 2025
Metric / unit 2024Group / At 1 August2024Group / Financing cash flows2024Group / Additions2024Group / Interest expenses2024Group / At 31 July Source
Liabilities
Bank borrowingsSingapore dollars thousands 1,520(528)-361,028 PDF p. 73
Lease liabilitiesSingapore dollars thousands 48(64)1172103 PDF p. 73
Asset
Pledged depositSingapore dollars thousands (615)(23)--(638) PDF p. 73
Definitions & sources

Original report: PDF p. 73 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group cash and pledged deposit reconciliation / Note14

3 metrics

Units appear below each metric. Scroll to compare years

Group cash and pledged deposit reconciliation / Note14 from Annual Report 2025
Metric / unit 2025Group / as at 31 July 20252024Group / as at 31 July 2024 Source
Cash and pledged deposit reconciliation
Cash and cash equivalentsSingapore dollars thousands 10,63414,194 PDF p. 102
Pledged fixed depositSingapore dollars thousands -(638) PDF p. 102
Cash and cash equivalentsSingapore dollars thousands 10,63413,556 PDF p. 102
Definitions & sources

Original report: PDF p. 102 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group statement of financial position

26 metrics

Units appear below each metric. Scroll to compare years

Group statement of financial position from Annual Report 2025
Metric / unit 2023Group / as at 31 July 2023 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 37,885 PDF p. 75
Right-of-use assetsSingapore dollars thousands 45 PDF p. 75
Investment securitiesSingapore dollars thousands 4,208 PDF p. 75
Long-term receivablesSingapore dollars thousands 6,305 PDF p. 75
SubsidiariesSingapore dollars thousands – PDF p. 75
Deferred tax assetsSingapore dollars thousands 151 PDF p. 75
Total non-current assetsSingapore dollars thousands 48,594 PDF p. 75
Current assets
Trade and other receivablesSingapore dollars thousands 323 PDF p. 75
PrepaymentSingapore dollars thousands 62 PDF p. 75
Investment securitiesSingapore dollars thousands 498 PDF p. 75
Cash and bank balancesSingapore dollars thousands 13,397 PDF p. 75
Total current assetsSingapore dollars thousands 14,280 PDF p. 75
TOTAL ASSETSSingapore dollars thousands 62,874 PDF p. 75
Equity attributable to owners of the Company
Share capitalSingapore dollars thousands 35,016 PDF p. 75
ReservesSingapore dollars thousands 24,922 PDF p. 75
Total equitySingapore dollars thousands 59,938 PDF p. 75
Non-current liabilities
Loans and borrowingsSingapore dollars thousands 1,020 PDF p. 75
Lease liabilitiesSingapore dollars thousands 1 PDF p. 75
Total non-current liabilitiesSingapore dollars thousands 1,021 PDF p. 75
Current liabilities
Trade and other payablesSingapore dollars thousands 813 PDF p. 75
Current tax payableSingapore dollars thousands 555 PDF p. 75
Loans and borrowingsSingapore dollars thousands 500 PDF p. 75
Lease liabilitiesSingapore dollars thousands 47 PDF p. 75
Total current liabilitiesSingapore dollars thousands 1,915 PDF p. 75
Total liabilitiesSingapore dollars thousands 2,936 PDF p. 75
TOTAL EQUITY AND LIABILITIESSingapore dollars thousands 62,874 PDF p. 75
Definitions & sources

Original report: PDF p. 75 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Company statement of financial position

26 metrics

Units appear below each metric. Scroll to compare years

Company statement of financial position from Annual Report 2025
Metric / unit 2023Company / as at 31 July 2023 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 15 PDF p. 75
Right-of-use assetsSingapore dollars thousands 45 PDF p. 75
Investment securitiesSingapore dollars thousands – PDF p. 75
Long-term receivablesSingapore dollars thousands – PDF p. 75
SubsidiariesSingapore dollars thousands 49,646 PDF p. 75
Deferred tax assetsSingapore dollars thousands – PDF p. 75
Total non-current assetsSingapore dollars thousands 49,706 PDF p. 75
Current assets
Trade and other receivablesSingapore dollars thousands 118 PDF p. 75
PrepaymentSingapore dollars thousands 47 PDF p. 75
Investment securitiesSingapore dollars thousands 498 PDF p. 75
Cash and bank balancesSingapore dollars thousands 11,579 PDF p. 75
Total current assetsSingapore dollars thousands 12,242 PDF p. 75
TOTAL ASSETSSingapore dollars thousands 61,948 PDF p. 75
Equity attributable to owners of the Company
Share capitalSingapore dollars thousands 35,016 PDF p. 75
ReservesSingapore dollars thousands 24,531 PDF p. 75
Total equitySingapore dollars thousands 59,547 PDF p. 75
Non-current liabilities
Loans and borrowingsSingapore dollars thousands 1,020 PDF p. 75
Lease liabilitiesSingapore dollars thousands 1 PDF p. 75
Total non-current liabilitiesSingapore dollars thousands 1,021 PDF p. 75
Current liabilities
Trade and other payablesSingapore dollars thousands 313 PDF p. 75
Current tax payableSingapore dollars thousands 520 PDF p. 75
Loans and borrowingsSingapore dollars thousands 500 PDF p. 75
Lease liabilitiesSingapore dollars thousands 47 PDF p. 75
Total current liabilitiesSingapore dollars thousands 1,380 PDF p. 75
Total liabilitiesSingapore dollars thousands 2,401 PDF p. 75
TOTAL EQUITY AND LIABILITIESSingapore dollars thousands 61,948 PDF p. 75
Definitions & sources

Original report: PDF p. 75 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group consolidated profit or loss and comprehensive income

22 metrics

Units appear below each metric. Scroll to compare years

Group consolidated profit or loss and comprehensive income from Annual Report 2025
Metric / unit 2023Group / year ended 31 July 2023 Source
income
RevenueSingapore dollars thousands 4,469 PDF p. 74
Other incomeSingapore dollars thousands 330 PDF p. 74
Revenue and other income subtotal (unlabelled in source)Singapore dollars thousands 4,799 PDF p. 74
Loss on disposal of investmentsSingapore dollars thousands (18) PDF p. 74
Staff costsSingapore dollars thousands (1,496) PDF p. 74
Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands (613) PDF p. 74
Finance costsSingapore dollars thousands (51) PDF p. 74
Hotel operating expensesSingapore dollars thousands (2,028) PDF p. 74
Reversal of/(Impairment) of freehold buildingSingapore dollars thousands (970) PDF p. 74
Other operating expensesSingapore dollars thousands (1,013) PDF p. 74
Profit/(Loss) before taxationSingapore dollars thousands (1,390) PDF p. 74
TaxationSingapore dollars thousands 219 PDF p. 74
Profit/(Loss) for the yearSingapore dollars thousands (1,171) PDF p. 74
Components of other comprehensive (loss)/income that will not be
Remeasurement of defined benefit obligationSingapore dollars thousands (13) PDF p. 74
Net (loss)/gain on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands 1,460 PDF p. 74
Components of other comprehensive loss that will be reclassified to
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands (1,138) PDF p. 74
Total other comprehensive (loss)/income, net of taxationSingapore dollars thousands 309 PDF p. 74
TOTAL COMPREHENSIVE INCOME/(LOSS) FOR THE YEARSingapore dollars thousands (862) PDF p. 74
Profit/(Loss) attributable to:
Owners of the CompanySingapore dollars thousands (1,171) PDF p. 74
Total comprehensive income/(loss) attributable to:
Owners of the CompanySingapore dollars thousands (862) PDF p. 74
Profit/(Loss) per share attributable to owners of the Company
Basic profit/(loss) per share (cents)Singapore cents per share (0.53) PDF p. 74
Diluted profit/(loss) per share (cents)Singapore cents per share (0.38) PDF p. 74
Definitions & sources

Original report: PDF p. 74 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group changes in equity / 2023

11 metrics

Units appear below each metric. Scroll to compare years

Group changes in equity / 2023 from Annual Report 2025
Metric / unit 2023Group / Share capital2023Group / Treasury shares2023Group / Fair value adjustment reserve2023Group / Foreign currency translation reserve2023Group / Warrant reserve2023Group / Retained earnings2023Group / Total equity Source
equity
Balance at 1 August 2022Singapore dollars thousands 32,992(187)(2,507)(4,774)–32,50058,024 PDF p. 77
Loss for the yearSingapore dollars thousands –––––(1,171)(1,171) PDF p. 77
Remeasurement of defined benefit obligationSingapore dollars thousands –––––(13)(13) PDF p. 77
Net gain on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands ––1,460–––1,460 PDF p. 77
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands –––(1,138)––(1,138) PDF p. 77
Total other comprehensive income/(loss)Singapore dollars thousands ––1,460(1,138)–(13)309 PDF p. 77
Total comprehensive income/(loss) for the financial yearSingapore dollars thousands ––1,460(1,138)–(1,184)(862) PDF p. 77
Issuance of warrants, net of transaction costsSingapore dollars thousands ––––926–926 PDF p. 77
Exercise of warrantsSingapore dollars thousands 2,024–––(174)–1,850 PDF p. 77
Transactions with owners subtotal (unlabelled in source)Singapore dollars thousands 2,024–––752–2,776 PDF p. 77
Balance at 31 July 2023Singapore dollars thousands 35,016(187)(1,047)(5,912)75231,31659,938 PDF p. 77
Definitions & sources

Original report: PDF p. 77 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group consolidated cash flows

33 metrics

Units appear below each metric. Scroll to compare years

Group consolidated cash flows from Annual Report 2025
Metric / unit 2023Group / year ended 31 July 2023 Source
Operating activities
Profit/(Loss) before taxationSingapore dollars thousands (1,390) PDF p. 78
Adjustments for:
– Defined benefit costsSingapore dollars thousands 58 PDF p. 78
– Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands 613 PDF p. 78
– Finance costsSingapore dollars thousands 51 PDF p. 78
– (Reversal of)/Impairment of freehold buildingSingapore dollars thousands 970 PDF p. 78
– Loss on disposal of property, plant and equipmentSingapore dollars thousands 2 PDF p. 78
– Interest incomeSingapore dollars thousands (329) PDF p. 78
Operating cash flows before movements in working capitalSingapore dollars thousands (25) PDF p. 78
Changes in working capital:
– Trade and other receivablesSingapore dollars thousands (83) PDF p. 78
– PrepaymentSingapore dollars thousands (14) PDF p. 78
– Short-term investment securitiesSingapore dollars thousands 2,830 PDF p. 78
– Trade and other payablesSingapore dollars thousands 242 PDF p. 78
– Contribution or benefits paid to retirement benefitsSingapore dollars thousands (69) PDF p. 78
Cash generated from operationsSingapore dollars thousands 2,881 PDF p. 78
Tax (paid)/refundSingapore dollars thousands 68 PDF p. 78
Net cash flows generated from operating activitiesSingapore dollars thousands 2,949 PDF p. 78
Investing activities
Shareholder loans to investee companiesSingapore dollars thousands (138) PDF p. 78
Interest receivedSingapore dollars thousands 259 PDF p. 78
Investment securitiesSingapore dollars thousands – PDF p. 78
Purchase of property, plant and equipmentSingapore dollars thousands (53) PDF p. 78
Net cash flows generated from investing activitiesSingapore dollars thousands 68 PDF p. 78
Financing activities
Interest paidSingapore dollars thousands (49) PDF p. 78
Proceeds from issuance of warrants, net of transaction costsSingapore dollars thousands 926 PDF p. 78
Proceeds from exercise of warrantsSingapore dollars thousands 1,850 PDF p. 78
Purchase and cancellation of ordinary sharesSingapore dollars thousands – PDF p. 78
Repayment of borrowingsSingapore dollars thousands (480) PDF p. 78
Repayment of lease liabilitiesSingapore dollars thousands (62) PDF p. 78
Movement in pledged depositSingapore dollars thousands (15) PDF p. 78
Net cash flow (used in)/generated from financing activitiesSingapore dollars thousands 2,170 PDF p. 78
Net increase in cash and cash equivalentsSingapore dollars thousands 5,187 PDF p. 78
Cash and cash equivalents at beginning of financial yearSingapore dollars thousands 7,674 PDF p. 78
Effect of exchange rate changes on balances held in foreign currencySingapore dollars thousands (79) PDF p. 78
Cash and cash equivalents at end of financial yearSingapore dollars thousands 12,782 PDF p. 78
Definitions & sources

Original report: PDF p. 78 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group financing reconciliation / 2023

3 metrics

Units appear below each metric. Scroll to compare years

Group financing reconciliation / 2023 from Annual Report 2025
Metric / unit 2023Group / At 1 August2023Group / Financing cash flows2023Group / Additions2023Group / Interest expenses2023Group / At 31 July Source
Liabilities
Bank borrowingsSingapore dollars thousands 2,000(529)–491,520 PDF p. 79
Lease liabilitiesSingapore dollars thousands 108(62)–248 PDF p. 79
Asset
Pledged depositSingapore dollars thousands (600)(15)––(615) PDF p. 79
Definitions & sources

Original report: PDF p. 79 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group statement of financial position

26 metrics

Units appear below each metric. Scroll to compare years

Group statement of financial position from Annual Report 2025
Metric / unit 2022Group / as at 31 July 2022 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 40,482 PDF p. 82
Right-of-use assetsSingapore dollars thousands 103 PDF p. 82
Investment securitiesSingapore dollars thousands 2,748 PDF p. 82
Long-term receivablesSingapore dollars thousands 6,167 PDF p. 82
SubsidiariesSingapore dollars thousands – PDF p. 82
Deferred tax assetsSingapore dollars thousands – PDF p. 82
Total non-current assetsSingapore dollars thousands 49,500 PDF p. 82
Current assets
Trade and other receivablesSingapore dollars thousands 172 PDF p. 82
PrepaymentSingapore dollars thousands 48 PDF p. 82
Investment securitiesSingapore dollars thousands 3,328 PDF p. 82
Cash and bank balancesSingapore dollars thousands 8,274 PDF p. 82
Total current assetsSingapore dollars thousands 11,822 PDF p. 82
TOTAL ASSETSSingapore dollars thousands 61,322 PDF p. 82
Equity attributable to owners of the Company
Share capitalSingapore dollars thousands 32,992 PDF p. 82
ReservesSingapore dollars thousands 25,032 PDF p. 82
Total equitySingapore dollars thousands 58,024 PDF p. 82
Non-current liabilities
Loans and borrowingsSingapore dollars thousands 1,500 PDF p. 82
Lease liabilitiesSingapore dollars thousands 48 PDF p. 82
Total non-current liabilitiesSingapore dollars thousands 1,548 PDF p. 82
Current liabilities
Trade and other payablesSingapore dollars thousands 635 PDF p. 82
Current tax payableSingapore dollars thousands 555 PDF p. 82
Loans and borrowingsSingapore dollars thousands 500 PDF p. 82
Lease liabilitiesSingapore dollars thousands 60 PDF p. 82
Total current liabilitiesSingapore dollars thousands 1,750 PDF p. 82
Total liabilitiesSingapore dollars thousands 3,298 PDF p. 82
TOTAL EQUITY AND LIABILITIESSingapore dollars thousands 61,322 PDF p. 82
Definitions & sources

Original report: PDF p. 82 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Company statement of financial position

26 metrics

Units appear below each metric. Scroll to compare years

Company statement of financial position from Annual Report 2025
Metric / unit 2022Company / as at 31 July 2022 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 22 PDF p. 82
Right-of-use assetsSingapore dollars thousands 103 PDF p. 82
Investment securitiesSingapore dollars thousands – PDF p. 82
Long-term receivablesSingapore dollars thousands – PDF p. 82
SubsidiariesSingapore dollars thousands 54,810 PDF p. 82
Deferred tax assetsSingapore dollars thousands – PDF p. 82
Total non-current assetsSingapore dollars thousands 54,935 PDF p. 82
Current assets
Trade and other receivablesSingapore dollars thousands 50 PDF p. 82
PrepaymentSingapore dollars thousands 33 PDF p. 82
Investment securitiesSingapore dollars thousands 3,328 PDF p. 82
Cash and bank balancesSingapore dollars thousands 7,137 PDF p. 82
Total current assetsSingapore dollars thousands 10,548 PDF p. 82
TOTAL ASSETSSingapore dollars thousands 65,483 PDF p. 82
Equity attributable to owners of the Company
Share capitalSingapore dollars thousands 32,992 PDF p. 82
ReservesSingapore dollars thousands 29,659 PDF p. 82
Total equitySingapore dollars thousands 62,651 PDF p. 82
Non-current liabilities
Loans and borrowingsSingapore dollars thousands 1,500 PDF p. 82
Lease liabilitiesSingapore dollars thousands 48 PDF p. 82
Total non-current liabilitiesSingapore dollars thousands 1,548 PDF p. 82
Current liabilities
Trade and other payablesSingapore dollars thousands 204 PDF p. 82
Current tax payableSingapore dollars thousands 520 PDF p. 82
Loans and borrowingsSingapore dollars thousands 500 PDF p. 82
Lease liabilitiesSingapore dollars thousands 60 PDF p. 82
Total current liabilitiesSingapore dollars thousands 1,284 PDF p. 82
Total liabilitiesSingapore dollars thousands 2,832 PDF p. 82
TOTAL EQUITY AND LIABILITIESSingapore dollars thousands 65,483 PDF p. 82
Definitions & sources

Original report: PDF p. 82 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group consolidated profit or loss and comprehensive income

22 metrics

Units appear below each metric. Scroll to compare years

Group consolidated profit or loss and comprehensive income from Annual Report 2025
Metric / unit 2022Group / year ended 31 July 2022 Source
income
RevenueSingapore dollars thousands 1,921 PDF p. 81
Other incomeSingapore dollars thousands 206 PDF p. 81
Revenue and other income subtotal (unlabelled in source)Singapore dollars thousands 2,127 PDF p. 81
Fair value loss on short-term investments at fair value through profit or loss (“FVPL”)Singapore dollars thousands (307) PDF p. 81
Loss on disposal of investmentsSingapore dollars thousands – PDF p. 81
Staff costsSingapore dollars thousands (1,395) PDF p. 81
Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands (998) PDF p. 81
Finance costsSingapore dollars thousands (617) PDF p. 81
Hotel operating expensesSingapore dollars thousands (867) PDF p. 81
Impairment of freehold buildingSingapore dollars thousands – PDF p. 81
Other operating expensesSingapore dollars thousands (1,285) PDF p. 81
Loss before taxationSingapore dollars thousands (3,342) PDF p. 81
TaxationSingapore dollars thousands 36 PDF p. 81
Loss for the yearSingapore dollars thousands (3,306) PDF p. 81
Components of other comprehensive (loss)/income that will not be
Remeasurement of defined benefit obligationSingapore dollars thousands – PDF p. 81
Net gain/(loss) on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands (350) PDF p. 81
Components of other comprehensive loss that will be reclassified to
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands (3,930) PDF p. 81
Total other comprehensive income/(loss), net of taxationSingapore dollars thousands (4,280) PDF p. 81
TOTAL COMPREHENSIVE LOSS FOR THE YEARSingapore dollars thousands (7,586) PDF p. 81
Loss attributable to:
Owners of the CompanySingapore dollars thousands (3,306) PDF p. 81
Total comprehensive loss attributable to:
Owners of the CompanySingapore dollars thousands (7,586) PDF p. 81
Loss per share attributable to owners of the Company
Basic and diluted loss per share (cents)Singapore cents per share (1.51) PDF p. 81
Definitions & sources

Original report: PDF p. 81 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group changes in equity / 2022

7 metrics

Units appear below each metric. Scroll to compare years

Group changes in equity / 2022 from Annual Report 2025
Metric / unit 2022Group / Share capital2022Group / Treasury shares2022Group / Fair value adjustment reserve2022Group / Foreign currency translation reserve2022Group / Retained earnings2022Group / Total equity Source
equity
Balance at 1 August 2021Singapore dollars thousands 32,992(187)(2,157)(844)35,80665,610 PDF p. 84
Loss for the yearSingapore dollars thousands ––––(3,306)(3,306) PDF p. 84
Net loss on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands ––(350)––(350) PDF p. 84
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands –––(3,930)–(3,930) PDF p. 84
Total other comprehensive lossSingapore dollars thousands ––(350)(3,930)–(4,280) PDF p. 84
Total comprehensive loss for the financial yearSingapore dollars thousands ––(350)(3,930)(3,306)(7,586) PDF p. 84
Balance at 31 July 2022Singapore dollars thousands 32,992(187)(2,507)(4,774)32,50058,024 PDF p. 84
Definitions & sources

Original report: PDF p. 84 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group consolidated cash flows

32 metrics

Units appear below each metric. Scroll to compare years

Group consolidated cash flows from Annual Report 2025
Metric / unit 2022Group / year ended 31 July 2022 Source
Operating activities
Loss before taxationSingapore dollars thousands (3,342) PDF p. 85
Adjustments for:
– Defined benefit costsSingapore dollars thousands 46 PDF p. 85
– Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands 998 PDF p. 85
– Finance costsSingapore dollars thousands 617 PDF p. 85
– Impairment of freehold buildingSingapore dollars thousands – PDF p. 85
– Loss on disposal of property, plant and equipmentSingapore dollars thousands 8 PDF p. 85
– Fair value loss on short-term investment securitiesSingapore dollars thousands 307 PDF p. 85
– Interest incomeSingapore dollars thousands (102) PDF p. 85
Operating cash flows before movements in working capitalSingapore dollars thousands (1,468) PDF p. 85
Changes in working capital:
– Trade and other receivablesSingapore dollars thousands 1,465 PDF p. 85
– PrepaymentSingapore dollars thousands 15 PDF p. 85
– Short-term investment securitiesSingapore dollars thousands 538 PDF p. 85
– Trade and other payablesSingapore dollars thousands (80) PDF p. 85
– Contribution or benefits paid to retirement benefitsSingapore dollars thousands (61) PDF p. 85
Cash generated from operationsSingapore dollars thousands 409 PDF p. 85
Tax refund/(paid)Singapore dollars thousands (6) PDF p. 85
Net cash flows generated from operating activitiesSingapore dollars thousands 403 PDF p. 85
Investing activities
Shareholder loans to investee companiesSingapore dollars thousands (538) PDF p. 85
Interest receivedSingapore dollars thousands 102 PDF p. 85
Proceeds from sale of property, plant and equipmentSingapore dollars thousands 3 PDF p. 85
Purchase of property, plant and equipmentSingapore dollars thousands (33) PDF p. 85
Net cash flows generated from/(used in) investing activitiesSingapore dollars thousands (466) PDF p. 85
Financing activities
Interest paidSingapore dollars thousands (615) PDF p. 85
Proceeds from issuance of warrants, net of transaction costsSingapore dollars thousands – PDF p. 85
Proceeds from exercise of warrantsSingapore dollars thousands – PDF p. 85
Repayment of borrowingsSingapore dollars thousands (20,254) PDF p. 85
Repayment of lease liabilitiesSingapore dollars thousands (70) PDF p. 85
Net cash flow generated from/(used in) financing activitiesSingapore dollars thousands (20,939) PDF p. 85
Net increase/(decrease) in cash and cash equivalentsSingapore dollars thousands (21,002) PDF p. 85
Cash and cash equivalents at beginning of financial yearSingapore dollars thousands 29,346 PDF p. 85
Effect of exchange rate changes on balances held in foreign currencySingapore dollars thousands (70) PDF p. 85
Cash and cash equivalents at end of financial yearSingapore dollars thousands 8,274 PDF p. 85
Definitions & sources

Original report: PDF p. 85 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group financing reconciliation / 2022

2 metrics

Units appear below each metric. Scroll to compare years

Group financing reconciliation / 2022 from Annual Report 2025
Metric / unit 2022Group / At 1 August2022Group / Financing cash flows2022Group / Additions2022Group / Interest expenses2022Group / Foreign exchange movement2022Group / At 31 July Source
Liabilities
Bank borrowingsSingapore dollars thousands 23,132(20,869)–615(878)2,000 PDF p. 86
Lease liabilitiesSingapore dollars thousands 60(70)1162–108 PDF p. 86
Definitions & sources

Original report: PDF p. 86 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group statement of financial position

27 metrics

Units appear below each metric. Scroll to compare years

Group statement of financial position from Annual Report 2025
Metric / unit 2021Group / as at 31 July 2021 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 46,080 PDF p. 78
Right-of-use assetsSingapore dollars thousands 59 PDF p. 78
Investment securitiesSingapore dollars thousands 3,098 PDF p. 78
Long-term receivablesSingapore dollars thousands 5,629 PDF p. 78
SubsidiariesSingapore dollars thousands – PDF p. 78
Total non-current assetsSingapore dollars thousands 54,866 PDF p. 78
Current assets
Trade and other receivablesSingapore dollars thousands 1,700 PDF p. 78
PrepaymentSingapore dollars thousands 63 PDF p. 78
Investment securitiesSingapore dollars thousands 4,173 PDF p. 78
Cash and bank balancesSingapore dollars thousands 29,346 PDF p. 78
Total current assetsSingapore dollars thousands 35,282 PDF p. 78
TOTAL ASSETSSingapore dollars thousands 90,148 PDF p. 78
Equity attributable to owners of the Company
Share capitalSingapore dollars thousands 32,992 PDF p. 78
ReservesSingapore dollars thousands 32,618 PDF p. 78
Total equitySingapore dollars thousands 65,610 PDF p. 78
Non-current liabilities
Loans and borrowingsSingapore dollars thousands 1,958 PDF p. 78
Lease liabilitiesSingapore dollars thousands 6 PDF p. 78
Total non-current liabilitiesSingapore dollars thousands 1,964 PDF p. 78
Current liabilities
Trade and other payablesSingapore dollars thousands 749 PDF p. 78
Current tax payableSingapore dollars thousands 597 PDF p. 78
Loans and borrowingsSingapore dollars thousands 21,174 PDF p. 78
Lease liabilitiesSingapore dollars thousands 54 PDF p. 78
Total current liabilitiesSingapore dollars thousands 22,574 PDF p. 78
Total liabilitiesSingapore dollars thousands 24,538 PDF p. 78
Net current assetsSingapore dollars thousands 12,708 PDF p. 78
Net assetsSingapore dollars thousands 65,610 PDF p. 78
TOTAL EQUITY AND LIABILITIESSingapore dollars thousands 90,148 PDF p. 78
Definitions & sources

Original report: PDF p. 78 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Company statement of financial position

27 metrics

Units appear below each metric. Scroll to compare years

Company statement of financial position from Annual Report 2025
Metric / unit 2021Company / as at 31 July 2021 Source
Non-current assets
Property, plant and equipmentSingapore dollars thousands 37 PDF p. 78
Right-of-use assetsSingapore dollars thousands 59 PDF p. 78
Investment securitiesSingapore dollars thousands – PDF p. 78
Long-term receivablesSingapore dollars thousands – PDF p. 78
SubsidiariesSingapore dollars thousands 35,795 PDF p. 78
Total non-current assetsSingapore dollars thousands 35,891 PDF p. 78
Current assets
Trade and other receivablesSingapore dollars thousands 395 PDF p. 78
PrepaymentSingapore dollars thousands 48 PDF p. 78
Investment securitiesSingapore dollars thousands 4,173 PDF p. 78
Cash and bank balancesSingapore dollars thousands 27,500 PDF p. 78
Total current assetsSingapore dollars thousands 32,116 PDF p. 78
TOTAL ASSETSSingapore dollars thousands 68,007 PDF p. 78
Equity attributable to owners of the Company
Share capitalSingapore dollars thousands 32,992 PDF p. 78
ReservesSingapore dollars thousands 32,180 PDF p. 78
Total equitySingapore dollars thousands 65,172 PDF p. 78
Non-current liabilities
Loans and borrowingsSingapore dollars thousands 1,958 PDF p. 78
Lease liabilitiesSingapore dollars thousands 6 PDF p. 78
Total non-current liabilitiesSingapore dollars thousands 1,964 PDF p. 78
Current liabilities
Trade and other payablesSingapore dollars thousands 215 PDF p. 78
Current tax payableSingapore dollars thousands 560 PDF p. 78
Loans and borrowingsSingapore dollars thousands 42 PDF p. 78
Lease liabilitiesSingapore dollars thousands 54 PDF p. 78
Total current liabilitiesSingapore dollars thousands 871 PDF p. 78
Total liabilitiesSingapore dollars thousands 2,835 PDF p. 78
Net current assetsSingapore dollars thousands 31,245 PDF p. 78
Net assetsSingapore dollars thousands 65,172 PDF p. 78
TOTAL EQUITY AND LIABILITIESSingapore dollars thousands 68,007 PDF p. 78
Definitions & sources

Original report: PDF p. 78 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group consolidated profit or loss and comprehensive income

19 metrics

Units appear below each metric. Scroll to compare years

Group consolidated profit or loss and comprehensive income from Annual Report 2025
Metric / unit 2021Group / year ended 31 July 2021 Source
income
RevenueSingapore dollars thousands 1,040 PDF p. 77
Other incomeSingapore dollars thousands 684 PDF p. 77
Revenue and other income subtotal (unlabelled in source)Singapore dollars thousands 1,724 PDF p. 77
Fair value loss on short-term investments at fair value through profit or loss (“FVPL”)Singapore dollars thousands – PDF p. 77
Staff costsSingapore dollars thousands (1,348) PDF p. 77
Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands (1,251) PDF p. 77
Finance costsSingapore dollars thousands (892) PDF p. 77
Hotel operating expensesSingapore dollars thousands (653) PDF p. 77
Other operating expensesSingapore dollars thousands (1,132) PDF p. 77
Loss before taxationSingapore dollars thousands (3,552) PDF p. 77
TaxationSingapore dollars thousands (113) PDF p. 77
Loss for the yearSingapore dollars thousands (3,665) PDF p. 77
Components of other comprehensive loss that will not be reclassified
to profit or loss, net of taxation Net loss on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands (1,597) PDF p. 77
Components of other comprehensive loss that will be reclassified to
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands 579 PDF p. 77
Total other comprehensive loss, net of taxationSingapore dollars thousands (1,018) PDF p. 77
TOTAL COMPREHENSIVE LOSS FOR THE YEARSingapore dollars thousands (4,683) PDF p. 77
Loss attributable to:
Owners of the CompanySingapore dollars thousands (3,665) PDF p. 77
Total comprehensive loss attributable to:
Owners of the CompanySingapore dollars thousands (4,683) PDF p. 77
Loss per share attributable to owners of the Company
Basic and diluted loss per share (cents)Singapore cents per share (1.67) PDF p. 77
Definitions & sources

Original report: PDF p. 77 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group changes in equity / 2021

7 metrics

Units appear below each metric. Scroll to compare years

Group changes in equity / 2021 from Annual Report 2025
Metric / unit 2021Group / Share capital2021Group / Treasury shares2021Group / Fair value adjustment reserve2021Group / Foreign currency translation reserve2021Group / Retained earnings2021Group / Total equity Source
equity
Balance at 1 August 2020Singapore dollars thousands 32,992(187)(560)(1,423)39,47170,293 PDF p. 79
Loss for the yearSingapore dollars thousands ––––(3,665)(3,665) PDF p. 79
Net loss on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands ––(1,597)––(1,597) PDF p. 79
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands –––579–579 PDF p. 79
Total other comprehensive lossSingapore dollars thousands ––(1,597)579–(1,018) PDF p. 79
Total comprehensive loss for the financial yearSingapore dollars thousands ––(1,597)579(3,665)(4,683) PDF p. 79
Balance at 31 July 2021Singapore dollars thousands 32,992(187)(2,157)(844)35,80665,610 PDF p. 79
Definitions & sources

Original report: PDF p. 79 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group consolidated cash flows

28 metrics

Units appear below each metric. Scroll to compare years

Group consolidated cash flows from Annual Report 2025
Metric / unit 2021Group / year ended 31 July 2021 Source
Operating activities
Loss before taxationSingapore dollars thousands (3,552) PDF p. 80
Adjustments for:
– Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands 1,251 PDF p. 80
– Finance costsSingapore dollars thousands 892 PDF p. 80
– Loss on disposal of property, plant and equipmentSingapore dollars thousands 2 PDF p. 80
– Fair value loss/(gain) on short-term investment securitiesSingapore dollars thousands (55) PDF p. 80
– Interest incomeSingapore dollars thousands (125) PDF p. 80
Operating cash flows before movements in working capitalSingapore dollars thousands (1,587) PDF p. 80
Changes in working capital:
– Trade and other receivablesSingapore dollars thousands (85) PDF p. 80
– PrepaymentSingapore dollars thousands 50 PDF p. 80
– Short-term investment securitiesSingapore dollars thousands 687 PDF p. 80
– Trade and other payablesSingapore dollars thousands (464) PDF p. 80
Cash generated from/(used in) operationsSingapore dollars thousands (1,399) PDF p. 80
Tax paidSingapore dollars thousands (153) PDF p. 80
Net cash flows generated from/(used in) operating activitiesSingapore dollars thousands (1,552) PDF p. 80
Investing activities
Shareholder loans to investee companiesSingapore dollars thousands (462) PDF p. 80
Interest receivedSingapore dollars thousands 125 PDF p. 80
Proceeds from sale of property, plant and equipmentSingapore dollars thousands – PDF p. 80
Purchase of property, plant and equipmentSingapore dollars thousands (1,901) PDF p. 80
Net cash flows used in investing activitiesSingapore dollars thousands (2,238) PDF p. 80
Financing activities
Interest paidSingapore dollars thousands (881) PDF p. 80
Proceeds from borrowingsSingapore dollars thousands 2,000 PDF p. 80
Repayment of borrowingsSingapore dollars thousands (1,700) PDF p. 80
Repayment of lease liabilitiesSingapore dollars thousands (204) PDF p. 80
Net cash flow used in financing activitiesSingapore dollars thousands (785) PDF p. 80
Net decrease in cash and cash equivalentsSingapore dollars thousands (4,575) PDF p. 80
Cash and cash equivalents at beginning of financial yearSingapore dollars thousands 33,886 PDF p. 80
Effect of exchange rate changes on balances held in foreign currencySingapore dollars thousands 35 PDF p. 80
Cash and cash equivalents at end of financial yearSingapore dollars thousands 29,346 PDF p. 80
Definitions & sources

Original report: PDF p. 80 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group financing reconciliation / 2021

2 metrics

Units appear below each metric. Scroll to compare years

Group financing reconciliation / 2021 from Annual Report 2025
Metric / unit 2021Group / At 1 August2021Group / Financing cash flows2021Group / Remeasurement adjustments2021Group / Interest expenses2021Group / Foreign exchange movement2021Group / At 31 July Source
Liabilities
Bank borrowingsSingapore dollars thousands 22,328(581)–88150423,132 PDF p. 81
Lease liabilitiesSingapore dollars thousands 311(204)(58)11–60 PDF p. 81
Definitions & sources

Original report: PDF p. 81 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

FY2021 original and reclassified figures / FY2022 Note26

7 metrics

Units appear below each metric. Scroll to compare years

FY2021 original and reclassified figures / FY2022 Note26 from Annual Report 2025
Metric / unit 2021Group / As previously reported2021Group / As reclassified Source
FY2021 comparative reclassifications / Note26
Consolidated statement of profit or loss and other comprehensive income Hotel operating expensesSingapore dollars thousands (303)(653) PDF p. 129
Other operating expensesSingapore dollars thousands (1,482)(1,132) PDF p. 129
Changes in working capital:
Trade and other receivablesSingapore dollars thousands (547)(85) PDF p. 129
Investing activities
Shareholder loans to investee companiesSingapore dollars thousands –(462) PDF p. 129
Financing activities
Interest paidSingapore dollars thousands –(881) PDF p. 129
Proceeds from borrowingsSingapore dollars thousands –2,000 PDF p. 129
Repayment of borrowingsSingapore dollars thousands (581)(1,700) PDF p. 129
Definitions & sources

Original report: PDF p. 129 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group profit or loss and comprehensive income / retained FY2023 original

22 metrics

Units appear below each metric. Scroll to compare years

Group profit or loss and comprehensive income / retained FY2023 original from Annual Report 2025
Metric / unit 2023Group / original year ended 31 July 2023 Source
income
RevenueSingapore dollars thousands 4,469 PDF p. 81
Other incomeSingapore dollars thousands 330 PDF p. 81
Revenue and other income subtotal (unlabelled in source)Singapore dollars thousands 4,799 PDF p. 81
Fair value loss on short-term investments at fair value through profit or loss (“FVPL”)Singapore dollars thousands – PDF p. 81
Loss on disposal of investmentsSingapore dollars thousands (18) PDF p. 81
Staff costsSingapore dollars thousands (1,496) PDF p. 81
Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands (613) PDF p. 81
Finance costsSingapore dollars thousands (51) PDF p. 81
Hotel operating expensesSingapore dollars thousands (2,028) PDF p. 81
Impairment of freehold buildingSingapore dollars thousands (970) PDF p. 81
Other operating expensesSingapore dollars thousands (1,013) PDF p. 81
Loss before taxationSingapore dollars thousands (1,390) PDF p. 81
TaxationSingapore dollars thousands 219 PDF p. 81
Loss for the yearSingapore dollars thousands (1,171) PDF p. 81
Components of other comprehensive (loss)/income that will not be
Remeasurement of defined benefit obligationSingapore dollars thousands (13) PDF p. 81
Net gain/(loss) on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands 1,460 PDF p. 81
Components of other comprehensive loss that will be reclassified to
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands (1,138) PDF p. 81
Total other comprehensive income/(loss), net of taxationSingapore dollars thousands 309 PDF p. 81
TOTAL COMPREHENSIVE LOSS FOR THE YEARSingapore dollars thousands (862) PDF p. 81
Loss attributable to:
Owners of the CompanySingapore dollars thousands (1,171) PDF p. 81
Total comprehensive loss attributable to:
Owners of the CompanySingapore dollars thousands (862) PDF p. 81
Loss per share attributable to owners of the Company
Basic and diluted loss per share (cents)Singapore cents per share (0.53) PDF p. 81
Definitions & sources

Original report: PDF p. 81 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group cash flows / retained FY2023 original

32 metrics

Units appear below each metric. Scroll to compare years

Group cash flows / retained FY2023 original from Annual Report 2025
Metric / unit 2023Group / original year ended 31 July 2023 Source
Operating activities
Loss before taxationSingapore dollars thousands (1,390) PDF p. 85
Adjustments for:
– Defined benefit costsSingapore dollars thousands 58 PDF p. 85
– Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands 613 PDF p. 85
– Finance costsSingapore dollars thousands 51 PDF p. 85
– Impairment of freehold buildingSingapore dollars thousands 970 PDF p. 85
– Loss on disposal of property, plant and equipmentSingapore dollars thousands 2 PDF p. 85
– Fair value loss on short-term investment securitiesSingapore dollars thousands – PDF p. 85
– Interest incomeSingapore dollars thousands (329) PDF p. 85
Operating cash flows before movements in working capitalSingapore dollars thousands (25) PDF p. 85
Changes in working capital:
– Trade and other receivablesSingapore dollars thousands (83) PDF p. 85
– PrepaymentSingapore dollars thousands (14) PDF p. 85
– Short-term investment securitiesSingapore dollars thousands 2,830 PDF p. 85
– Trade and other payablesSingapore dollars thousands 242 PDF p. 85
– Contribution or benefits paid to retirement benefitsSingapore dollars thousands (69) PDF p. 85
Cash generated from operationsSingapore dollars thousands 2,881 PDF p. 85
Tax refund/(paid)Singapore dollars thousands 68 PDF p. 85
Net cash flows generated from operating activitiesSingapore dollars thousands 2,949 PDF p. 85
Investing activities
Shareholder loans to investee companiesSingapore dollars thousands (138) PDF p. 85
Interest receivedSingapore dollars thousands 259 PDF p. 85
Proceeds from sale of property, plant and equipmentSingapore dollars thousands – PDF p. 85
Purchase of property, plant and equipmentSingapore dollars thousands (53) PDF p. 85
Net cash flows generated from/(used in) investing activitiesSingapore dollars thousands 68 PDF p. 85
Financing activities
Interest paidSingapore dollars thousands (49) PDF p. 85
Proceeds from issuance of warrants, net of transaction costsSingapore dollars thousands 926 PDF p. 85
Proceeds from exercise of warrantsSingapore dollars thousands 1,850 PDF p. 85
Repayment of borrowingsSingapore dollars thousands (480) PDF p. 85
Repayment of lease liabilitiesSingapore dollars thousands (62) PDF p. 85
Net cash flow generated from/(used in) financing activitiesSingapore dollars thousands 2,185 PDF p. 85
Net increase/(decrease) in cash and cash equivalentsSingapore dollars thousands 5,202 PDF p. 85
Cash and cash equivalents at beginning of financial yearSingapore dollars thousands 8,274 PDF p. 85
Effect of exchange rate changes on balances held in foreign currencySingapore dollars thousands (79) PDF p. 85
Cash and cash equivalents at end of financial yearSingapore dollars thousands 13,397 PDF p. 85
Definitions & sources

Original report: PDF p. 85 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group financing reconciliation / retained original 2023

2 metrics

Units appear below each metric. Scroll to compare years

Group financing reconciliation / retained original 2023 from Annual Report 2025
Metric / unit 2023Group / At 1 August2023Group / Financing cash flows2023Group / Additions2023Group / Interest expenses2023Group / Foreign exchange movement2023Group / At 31 July Source
Liabilities
Bank borrowingsSingapore dollars thousands 2,000(529)–49–1,520 PDF p. 86
Lease liabilitiesSingapore dollars thousands 108(62)–2–48 PDF p. 86
Definitions & sources

Original report: PDF p. 86 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group cash flows / retained FY2022 original

28 metrics

Units appear below each metric. Scroll to compare years

Group cash flows / retained FY2022 original from Annual Report 2025
Metric / unit 2022Group / original year ended 31 July 2022 Source
Operating activities
Loss before taxationSingapore dollars thousands (3,342) PDF p. 80
Adjustments for:
– Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands 998 PDF p. 80
– Finance costsSingapore dollars thousands 617 PDF p. 80
– Loss on disposal of property, plant and equipmentSingapore dollars thousands 8 PDF p. 80
– Fair value loss/(gain) on short-term investment securitiesSingapore dollars thousands 307 PDF p. 80
– Interest incomeSingapore dollars thousands (102) PDF p. 80
Operating cash flows before movements in working capitalSingapore dollars thousands (1,514) PDF p. 80
Changes in working capital:
– Trade and other receivablesSingapore dollars thousands 1,465 PDF p. 80
– PrepaymentSingapore dollars thousands 15 PDF p. 80
– Short-term investment securitiesSingapore dollars thousands 538 PDF p. 80
– Trade and other payablesSingapore dollars thousands (95) PDF p. 80
Cash generated from/(used in) operationsSingapore dollars thousands 409 PDF p. 80
Tax paidSingapore dollars thousands (6) PDF p. 80
Net cash flows generated from/(used in) operating activitiesSingapore dollars thousands 403 PDF p. 80
Investing activities
Shareholder loans to investee companiesSingapore dollars thousands (538) PDF p. 80
Interest receivedSingapore dollars thousands 102 PDF p. 80
Proceeds from sale of property, plant and equipmentSingapore dollars thousands 3 PDF p. 80
Purchase of property, plant and equipmentSingapore dollars thousands (33) PDF p. 80
Net cash flows used in investing activitiesSingapore dollars thousands (466) PDF p. 80
Financing activities
Interest paidSingapore dollars thousands (615) PDF p. 80
Proceeds from borrowingsSingapore dollars thousands – PDF p. 80
Repayment of borrowingsSingapore dollars thousands (20,254) PDF p. 80
Repayment of lease liabilitiesSingapore dollars thousands (70) PDF p. 80
Net cash flow used in financing activitiesSingapore dollars thousands (20,939) PDF p. 80
Net decrease in cash and cash equivalentsSingapore dollars thousands (21,002) PDF p. 80
Cash and cash equivalents at beginning of financial yearSingapore dollars thousands 29,346 PDF p. 80
Effect of exchange rate changes on balances held in foreign currencySingapore dollars thousands (70) PDF p. 80
Cash and cash equivalents at end of financial yearSingapore dollars thousands 8,274 PDF p. 80
Definitions & sources

Original report: PDF p. 80 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group profit or loss and comprehensive income / retained FY2021 original

21 metrics

Units appear below each metric. Scroll to compare years

Group profit or loss and comprehensive income / retained FY2021 original from Annual Report 2025
Metric / unit 2021Group / original year ended 31 July 2021 Source
income
RevenueSingapore dollars thousands 1,040 PDF p. 80
Other incomeSingapore dollars thousands 684 PDF p. 80
Revenue and other income subtotal (unlabelled in source)Singapore dollars thousands 1,724 PDF p. 80
Fair value loss on short-term investmentsSingapore dollars thousands – PDF p. 80
Loss on disposal of investmentsSingapore dollars thousands – PDF p. 80
Staff costsSingapore dollars thousands (1,348) PDF p. 80
Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands (1,251) PDF p. 80
Finance costsSingapore dollars thousands (892) PDF p. 80
Hotel operating expensesSingapore dollars thousands (303) PDF p. 80
Impairment of freehold propertySingapore dollars thousands – PDF p. 80
Other operating expensesSingapore dollars thousands (1,482) PDF p. 80
Loss before taxationSingapore dollars thousands (3,552) PDF p. 80
TaxationSingapore dollars thousands (113) PDF p. 80
Loss for the yearSingapore dollars thousands (3,665) PDF p. 80
Components of other comprehensive loss that will not be reclassified
to profit or loss, net of taxation Net loss on equity instruments designated at fair value through other comprehensive incomeSingapore dollars thousands (1,597) PDF p. 80
Components of other comprehensive loss that will be reclassified to
Foreign currency translation differences relating to foreign subsidiariesSingapore dollars thousands 579 PDF p. 80
Total other comprehensive loss, net of taxationSingapore dollars thousands (1,018) PDF p. 80
TOTAL COMPREHENSIVE LOSS FOR THE YEARSingapore dollars thousands (4,683) PDF p. 80
Loss attributable to:
Owners of the CompanySingapore dollars thousands (3,665) PDF p. 80
Total comprehensive loss attributable to:
Owners of the CompanySingapore dollars thousands (4,683) PDF p. 80
Loss per share attributable to owners of the Company
Basic and diluted loss per share (cents)Singapore cents per share (1.67) PDF p. 80
Definitions & sources

Original report: PDF p. 80 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Group cash flows / retained FY2021 original

30 metrics

Units appear below each metric. Scroll to compare years

Group cash flows / retained FY2021 original from Annual Report 2025
Metric / unit 2021Group / original year ended 31 July 2021 Source
Operating activities
Loss before taxationSingapore dollars thousands (3,552) PDF p. 83
Adjustments for:
Depreciation of property, plant and equipment and right-of-use assetsSingapore dollars thousands 1,251 PDF p. 83
Finance costsSingapore dollars thousands 892 PDF p. 83
Loss on disposal of property, plant and equipmentSingapore dollars thousands 2 PDF p. 83
Fair value (gain)/loss on short-term investment securitiesSingapore dollars thousands (55) PDF p. 83
Impairment loss recognised on property, plant and equipmentSingapore dollars thousands – PDF p. 83
Interest incomeSingapore dollars thousands (125) PDF p. 83
Operating cash flows before movements in working capitalSingapore dollars thousands (1,587) PDF p. 83
Changes in working capital:
InventoriesSingapore dollars thousands – PDF p. 83
Trade and other receivablesSingapore dollars thousands (547) PDF p. 83
PrepaymentSingapore dollars thousands 50 PDF p. 83
Short-term investment securitiesSingapore dollars thousands 687 PDF p. 83
Trade and other payablesSingapore dollars thousands (464) PDF p. 83
Cash (used in)/generated from operationsSingapore dollars thousands (1,861) PDF p. 83
Tax (paid)/refundSingapore dollars thousands (153) PDF p. 83
Net cash flows (used in)/generated from operating activitiesSingapore dollars thousands (2,014) PDF p. 83
Investing activities
Loans to third partiesSingapore dollars thousands – PDF p. 83
Prepayment of loan to third partySingapore dollars thousands – PDF p. 83
Interest receivedSingapore dollars thousands 125 PDF p. 83
Proceeds from sale of plant and equipmentSingapore dollars thousands – PDF p. 83
Purchase of property, plant and equipmentSingapore dollars thousands (1,901) PDF p. 83
Net cash flows used in investing activitiesSingapore dollars thousands (1,776) PDF p. 83
Financing activities
Dividends paidSingapore dollars thousands – PDF p. 83
Repayment of borrowingsSingapore dollars thousands (581) PDF p. 83
Repayment of lease liabilitiesSingapore dollars thousands (204) PDF p. 83
Net cash flow used in financing activitiesSingapore dollars thousands (785) PDF p. 83
Net decrease in cash and cash equivalentsSingapore dollars thousands (4,575) PDF p. 83
Cash and cash equivalents at beginning of financial yearSingapore dollars thousands 33,886 PDF p. 83
Effect of exchange rate changes on balances held in foreign currencySingapore dollars thousands 35 PDF p. 83
Cash and cash equivalents at end of financial yearSingapore dollars thousands 29,346 PDF p. 83
Definitions & sources

Original report: PDF p. 83 ↗

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

Where the money comes from

Segment information

By business

Information about reportable segments – 31 July 14 lines
Information about reportable segments – 31 July
Item / unit 2025Investment Holding segment2025Investment segment2025Asset Management segment2025Hotel segment2025Adjustment/Elimination2025Total2024Investment Holding segment2024Investment segment2024Asset Management segment2024Hotel segment2024Adjustment/Elimination2024Total Source
Revenue
External customers$'000 -132-5,923-6,055-681805,938-6,186 PDF p. 109PDF p. 110
Inter-segment revenue$'000 189--2,175(2,364)-169--553(722)- PDF p. 109PDF p. 110
Total revenue for reporting segments$'000 189132-8,098(2,364)6,055169681806,491(722)6,186 PDF p. 109PDF p. 110
Results
Gain on fair value of investments$'000 -61---61 PDF p. 109
Interest income$'000 -231-42-273-405-16-421 PDF p. 109PDF p. 110
Finance costs$'000 (15)----(15)(38)----(38) PDF p. 109PDF p. 110
Depreciation of property, plant and equipment and right-of-use assets$'000 (59)--(510)-(569)(66)--(544)-(610) PDF p. 109PDF p. 110
Reportable segment (loss)/profit before income tax$'000 (908)424-1,281-797(1,195)473554,292-3,625 PDF p. 109PDF p. 110
Tax (expense)/credit$'000 (14)--39-25 PDF p. 109
Capital expenditure
Additions to property, plant and equipment$'000 4--12-16---15-15 PDF p. 109PDF p. 110
Assets
Reportable segment assets$'000 20,0043,8801239,144-63,04022,265-1741,484-63,766 PDF p. 109PDF p. 110
Liabilities
Reportable segment liabilities$'000 277-5500-7821,373-5535-1,913 PDF p. 109PDF p. 110
Results
Reversal of impairment of freehold building$'000 ---2,910-2,910 PDF p. 110
Tax credit/(expense)$'000 518(3)-377-892 PDF p. 110
Notes

Segment results, assets and liabilities include items directly attributable to a segment.

Note A: Inter-segment revenues are eliminated on consolidation.

Values listed in column order: Investment Holding, Investment, Asset Management, Hotel, Adjustment/Elimination, Total.

By geography

Geographical information 6 lines
Geographical information
Item / unit 2025Group2024Group Source
Revenue
Singapore$'000 132248 PDF p. 111
Korea$'000 5,9235,938 PDF p. 111
Revenue total (unlabelled)$'000 6,0556,186 PDF p. 111
Non-current assets
Singapore$'000 5,9666,021 PDF p. 111
Korea$'000 42,17843,273 PDF p. 111
Non-current assets total (unlabelled)$'000 48,14449,294 PDF p. 111
Notes

Segment revenue is based on the geographical location of customers and segment assets are based on the geographical location of assets.

Debt

Borrowings

Contractual maturities of financial liabilities - Group (debt and lease rows)

Contractual maturities of financial liabilities - Group (debt and lease rows) — Group
Item / unit 2024Effective interest rate %2024Less than 1 year20241 to 5 years2024More than 5 years2024Total Source
2024 Financial liabilities
Loans and borrowings$'000 (rate in %) 2.75(522)(536)-(1,058) PDF p. 119
Lease liabilities$'000 (rate in %) 3.00(61)(45)-(106) PDF p. 119
Notes

Contractual maturities including estimated interest payments and excluding the impact of netting agreements. The 2025 Group lease row is in a separate table.

Contractual maturities - Group 2025 lease liabilities

Contractual maturities - Group 2025 lease liabilities — Group
Item / unit 2025Effective interest rate %2025Less than 1 year20251 to 5 years2025More than 5 years2025Total Source
2025 Financial liabilities
Lease liabilities$'000 (rate in %) 3.00(45)--(45) PDF p. 119
Notes

No loans and borrowings row is printed for Group 2025.

Contractual maturities - Company (debt and lease rows)

Contractual maturities - Company (debt and lease rows) — Company
Item / unit 2025Effective interest rate %2025Less than 1 year20251 to 5 years2025Total Source
2025 Financial liabilities
Lease liabilities$'000 (rate in %) 3.00(45)-(45) PDF p. 120
Notes

No loans and borrowings row printed for Company 2025.

Contractual maturities - Company 2024 (debt and lease rows)

Contractual maturities - Company 2024 (debt and lease rows) — Company
Item / unit 2024Effective interest rate %2024Less than 1 year20241 to 5 years2024Total Source
2024 Financial liabilities
Loans and borrowings$'000 (rate in %) 2.75(522)(536)(1,058) PDF p. 120
Lease liabilities$'000 (rate in %) 3.00(61)(45)(106) PDF p. 120
Notes

Contractual maturities including estimated interest payments.

Borrowing notes 3 tables

Loan and borrowing

Loan and borrowing
Item / unit 2025Group2024Group2025Company2024Company Source
Current
2.75% p.a. fixed rate SGD bank loan$'000 -500-500 PDF p. 105
Non-current
2.75% p.a. fixed rate SGD bank loan$'000 -528-528 PDF p. 105
Total
Total loan and borrowing$'000 -1,028-1,028 PDF p. 105
Notes

The 2.75% p.a. fixed rate SGD bank loan was repayable over 60 monthly instalments and repayment commenced in August 2021. The loan was secured by a fixed deposit. The loan was fully settled during the year.

Maturity column printed as 2026 for both rows. Row labels wrap across lines in source.

Note 10(b) Lease liabilities

Note 10(b) Lease liabilities
Item / unit 2025Group and Company2024Group and Company Source
Lease liabilities
Lease liabilities - current$'000 4559 PDF p. 98
Lease liabilities - non-current$'000 -44 PDF p. 98
Notes

The maturity analysis of lease liabilities is disclosed in Note 23. Total printed: 45 (2025), 103 (2024).

Statements of financial position - loans and borrowings and lease liabilities

Statements of financial position - loans and borrowings and lease liabilities
Item / unit 2025Group2024Group2025Company2024Company Source
Non-current liabilities
Loans and borrowings$'000 -528-528 PDF p. 69
Lease liabilities$'000 -44-44 PDF p. 69
Current liabilities
Loans and borrowings$'000 -500-500 PDF p. 69
Lease liabilities$'000 45594559 PDF p. 69
Notes

Note reference column (17, 10) omitted from values.

Payout

Dividends & distributions

Dividend policy

ItemValuePeriod / scopeSource
Dividend Policy The Company has adopted a dividend policy to formalise the principles and practices that the Board applies in considering the level of dividend payments, if any. Company, FY2025 PDF p. 49

Dividends declared and proposed

ItemValuePeriod / scopeSource
Total dividend declared ($’000) (note 4) Nil Group, five-year financial highlights; FY2025 and FY2024 both Nil (also 2021-2023) PDF p. 6

Payout

ItemValuePeriod / scopeSource
Dividend payout (%) Nil Group, five-year financial highlights; FY2025 and FY2024 both Nil (also 2021-2023) PDF p. 6

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Auditor’s report

Audit & risk signals

Audit opinion

ItemValuePeriod / scopeSource
Audit firm FORVIS MAZARS LLP Group and Company, FY ended 31 July 2025 PDF p. 67
Engagement partner Quek Siew Eng Group PDF p. 67
Opinion In our opinion, the accompanying financial statements of the Group and the statement of financial position of the Company are properly drawn up in accordance with the provisions of the Companies Act 1967 Group and Company, as at 31 July 2025 PDF p. 61

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

How to read these figures

Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.

Comparative figures follow Annual Report 2025, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.

Five full financial years ended 31 July 2021–2025. Monetary figures are Singapore dollars thousands and EPS Singapore cents. Group income/comprehensive income, equity, cash flows and financing reconciliations and Group/Company financial position are retained. Separate Company income, equity and cash-flow primary statements are not disclosed.

FY2022 Note26 explicitly discloses the FY2021 income and cash-flow reclassification table, retained separately. FY2021 income was reclassified in the FY2022 comparative: hotel operating expenses (303) to (653), other operating expenses (1,482) to (1,132), a 350 transfer with unchanged loss. The original income statement is retained. FY2023 originally reports basic and diluted loss per share (0.53), with warrants anti-dilutive; FY2024 comparative instead prints diluted (0.38) using 309,478,423 shares. Both original disclosed EPS treatments are retained; no original value is silently corrected. FY2024 diluted EPS is printed 1.38 in FY2024 and FY2025 notes/primaries, but disclosed profit 4,517 thousand and diluted denominator 328,566,457 yield 1.37 cents rounded. The original 1.38 is retained with this source arithmetic difference; no alternate denominator is inferred.

FY2021 original cash flow has receivable movement (547), operating cash (2,014) and investing cash (1,776). Later comparative moves 462 to shareholder loans: receivables (85), operating (1,552), investing (2,238). Financing originally reports combined borrowing cash (581), later split into proceeds 2,000, repayments (1,700), interest (881), total unchanged. Original cash flow is retained.

FY2022 later comparative separately presents defined benefit cost 46 and contributions (61), and changes payables movement (95) to (80). Operating cash before working capital (1,514) becomes (1,468), while final operating cash remains 403. Original cash flow retained. FY2023 later cash comparative excludes pledged deposit 615 at close and 600 at opening: financing 2,185 becomes 2,170, net movement 5,202 becomes 5,187, and closing cash 13,397 becomes 12,782. Original cash flow and original financing reconciliation without the pledged-deposit row are retained.

FY2024 depreciation in profit or loss is 611, while the cash-flow adjustment is 610. Note9 PPE depreciation 546 plus Note10 right-of-use depreciation 64 totals 610. Both printed primary amounts are retained, with the one-thousand source difference qualified; no rounding explanation is inferred.

FY2025 cash and bank balances 10,634 equals cash-flow cash; FY2024 cash and bank balances 14,194 less pledged 638 equals cash-flow cash 13,556. Financing reconciliation presents pledged deposits as a negative asset. The printed FY2025 cash caption Net increase in cash and cash equivalents accompanies a negative (2,843); original caption and sign retained.

EPS uses exact source-reported share counts: basic FY2025 236,833,573, FY2024 239,582,103, FY2023 220,494,069, FY2022/FY2021 219,074,844; diluted FY2025 325,817,927 and FY2024 328,566,457. Original FY2021 EPS note places a monetary thousands heading above Number of shares but the amounts are full shares; neither year-end nor subsequent warrant-expanded capital replaces the EPS denominator.

Unlabelled printed numeric subtotals are explicitly identified as unlabelled in source, without inventing an original caption. Equity transaction subtotals repeat component movements and must not be added twice. FY2023 introduces a warrant reserve column; prior six-column equity is mapped separately.

The FY2026 full-year results and annual-report extension announcements are supplemental, not a FY2026 audited annual report. The selected latest verified annual remains FY2025; five audited annual years are available. The 22 September 2026 SGX conditional waiver and 6 October 2026 ACRA rejection are distinct decisions, and an appeal is announced, not already approved.

These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.